Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022

Stock Price vs Company Growth
1d
3.2%
1w
6.3%
1m
8.2%
3m
37.7%
6m
45.7%
1y
13.9%
all
5.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 227 3.2%
158
232
Company Overview

Sales
9,205 Cr
Growth: 0.1%
Profit after Tax
-314 Cr
Growth: -9.5%
Large Cap
30,168 Cr
P/S: 3.3x
Industry P/S: 2.9x
Fundamentals

Sales (Cr) ₹ 9,205
Growth 0.1%
EBITDA 11.0%
P/S 3.3x
Dividend 0.1%
P/E -95.6x
Book Value ₹ 60.8
PEG Ratio -1298.1x
ROE -3.9%
P/B 3.5x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the India’s largest Pharmaceutical Company. PPL offers a portfolio of differentiated products and services through its global development and manufacturing facilities and a global distribution network in various countries.
Investors (6)
Followers (2)